In intrahepatic cholangiocarcinoma, high SOX9‐AS1 expression is related to shorter overall survival and recurrence‐free survival and promotes tumour growth and metastasis [32]. This evidence concerns the gene SOX9 and intrahepatic cholangiocarcinoma.